Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 1 de 1
Filtrar
Mais filtros

Bases de dados
Ano de publicação
Tipo de documento
País de afiliação
Intervalo de ano de publicação
1.
PDA J Pharm Sci Technol ; 63(6): 547-58, 2009.
Artigo em Inglês | MEDLINE | ID: mdl-20169861

RESUMO

The traditional approach to virus filter spiking studies (virus added to the feed solution before the start of filtration) can lead to oversized viral filtration systems because of the non-representative volumetric throughputs (L/m2) that can be seen with the addition of the virus spike. The reduction in throughput is thought to be caused by interactions that take place between the species in the virus stock solution alone, or in conjunction with the species in the drug product. The traditional approach assumes that virus filter log reduction value (LRV) is directly related to volumetric throughput and limits manufacturing scale designs to the volumetric throughput achieved in the spiking study. This article references previous work that shows that % flow decay is a more relevant critical parameter than volumetric throughput for a poly(vinylidene diflouride) (PVDF) parvovirus filter. Based on this work, one could design the manufacturing-scale viral filtration system to the representative volumetric throughput achieved without the virus spike and implement a flow decay limit in manufacturing to ensure virus LRV. RUNspike is a complementary method that can be easily implemented today and that goes one step further. The RUNspike method challenges the same total virus as the traditional method, but the virus is added at the end of the filtration, after the representative volumetric throughput has been demonstrated. Comparable RUNspike and traditional LRV data, at the same flow decay, bridges the gap and strengthens the case for the flow decay-based design approach.


Assuntos
Contaminação de Medicamentos/prevenção & controle , Filtração/métodos , Vírus , Indústria Farmacêutica/instrumentação , Indústria Farmacêutica/métodos , Parvovirus , Preparações Farmacêuticas/normas , Polivinil/química , Controle de Qualidade
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA